Purchases and Sales Made in Q2 2024 in Entrada Therapeutics, Inc. (TRDA)
This table provides information about the institutional ownership of Entrada Therapeutics, Inc. (TRDA) during Q2 2024. The information is specifically focused on institutions that hold shares of Entrada Therapeutics, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Aug 14, 2024
Q2 2024
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
BUY
|
- |
118+ 1.17% |
$1.4K - $1.94K
|
10.2K
$180K
|
|
Aug 08, 2024
Q2 2024
|
Federated Hermes, Inc.
Pittsburgh, PA |
BUY
|
- |
62+ 6.98% |
$735 - $1.02K
|
950
$16.7K
|
|
Aug 06, 2024
Q2 2024
|
Srs Capital Advisors, Inc.
Denver, CO |
BUY
|
- |
45New |
$533 - $740
|
45
$790
|
|
Aug 12, 2024
Q2 2024
|
C M Bidwell & Associates LTD
Honolulu, HI |
BUY
|
- |
29New |
$344 - $477
|
29
$509
|
|
Jul 19, 2024
Q2 2024
|
Nisa Investment Advisors, LLC
|
BUY
|
- |
27+ 87.1% |
$320 - $444
|
58
$1.02K
|
|
Jul 09, 2024
Q2 2024
|
Cwm, LLC
|
BUY
|
- |
16+ 1600.0% |
$190 - $263
|
17
$299
|
|
Jul 23, 2024
Q2 2024
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
Aug 15, 2024
Q2 2024
|
Pdt Partners, LLC
New York, NY |
SELL
|
- |
-15- 0.12% |
$178 - $247
|
12.5K
$220K
|
|
Aug 08, 2024
Q2 2024
|
Cornercap Investment Counsel Inc
Atlanta, GA |
SELL
|
- |
-129- 0.98% |
$1.53K - $2.12K
|
13K
$229K
|
|
Aug 08, 2024
Q2 2024
|
Plato Investment Management LTD
Sydney, C3 |
SELL
|
- |
-1.06K- 94.53% |
$12.5K - $17.4K
|
61
$1.07K
|
|
Aug 13, 2024
Q2 2024
|
Ubs Group Ag
|
SELL
|
- |
-1.65K- 7.05% |
$19.6K - $27.2K
|
21.8K
$383K
|
|
Aug 14, 2024
Q2 2024
|
Barclays PLC
London, X0 |
SELL
|
- |
-7.99K- 35.49% |
$94.7K - $131K
|
14.5K
$255K
|
|
Aug 14, 2024
Q2 2024
|
Squarepoint Ops LLC
New York, NY |
SELL
|
- |
-8.15K- 23.9% |
$96.6K - $134K
|
26K
$456K
|
|
Aug 14, 2024
Q2 2024
|
Northern Trust Corp
Chicago, IL |
SELL
|
- |
-9.03K- 4.53% |
$107K - $149K
|
190K
$3.34M
|
|
Aug 12, 2024
Q2 2024
|
Citigroup Inc
|
SELL
|
- |
-50.7K- 90.15% |
$601K - $835K
|
5.54K
$97.3K
|
|
Aug 14, 2024
Q2 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-58.5K- 54.4% |
$693K - $963K
|
49.1K
$861K
|
|
Oct 17, 2024
Q2 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-58.5K- 54.4% |
$693K - $963K
|
49.1K
$861K
|
|
Aug 13, 2024
Q2 2024
|
Advantage Alpha Capital Partners LP
San Francisco, CA |
SELL
|
- |
-91.1K- 99.98% |
$1.08M - $1.5M
|
20
$351
|
|
Aug 14, 2024
Q2 2024
|
Redmile Group, LLC
San Francisco, CA |
SELL
|
- |
-723K- 56.3% |
$8.56M - $11.9M
|
561K
$9.85M
|